OraSure Technologies Inc. (NASDAQ:OSUR) was downgraded by research analysts at BTIG Research from a “buy” rating to a “neutral” rating in a report issued on Monday.

Other equities research analysts have also issued research reports about the stock. Raymond James Financial Inc. lowered shares of OraSure Technologies from an “outperform” rating to a “market perform” rating and set a $8.00 price objective on the stock. in a report on Monday, June 13th. Canaccord Genuity increased their price objective on shares of OraSure Technologies from $7.00 to $10.00 and gave the stock a “buy” rating in a report on Wednesday, August 24th. Jefferies Group decreased their price objective on shares of OraSure Technologies from $8.50 to $8.00 and set a “buy” rating on the stock in a report on Thursday, August 4th. Mizuho reaffirmed an “outperform” rating and issued a $8.00 target price on shares of OraSure Technologies in a research note on Tuesday, July 5th. Finally, TheStreet lowered shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Friday, July 1st. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $8.58.

Shares of OraSure Technologies (NASDAQ:OSUR) opened at 8.65 on Monday. OraSure Technologies has a 12-month low of $4.39 and a 12-month high of $9.05. The firm has a market cap of $480.94 million, a price-to-earnings ratio of 41.19 and a beta of 1.25. The stock’s 50 day moving average is $7.55 and its 200-day moving average is $7.11.

OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.02. OraSure Technologies had a net margin of 10.08% and a return on equity of 7.60%. The firm had revenue of $31.36 million for the quarter, compared to analyst estimates of $31.15 million. During the same quarter in the prior year, the firm earned $0.03 EPS. The company’s revenue was up 3.2% on a year-over-year basis. On average, analysts anticipate that OraSure Technologies will post $0.27 EPS for the current fiscal year.

In related news, Director Charles W. Patrick sold 6,575 shares of the stock in a transaction that occurred on Friday, August 5th. The shares were sold at an average price of $7.24, for a total value of $47,603.00. Following the sale, the director now directly owns 77,209 shares in the company, valued at approximately $558,993.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jack E. Jerrett sold 68,686 shares of the stock in a transaction that occurred on Tuesday, August 30th. The shares were sold at an average price of $8.52, for a total transaction of $585,204.72. Following the completion of the sale, the senior vice president now owns 86,441 shares in the company, valued at $736,477.32. The disclosure for this sale can be found here. 7.80% of the stock is currently owned by corporate insiders.

Several hedge funds have recently made changes to their positions in the stock. Acadian Asset Management LLC increased its stake in shares of OraSure Technologies by 227.5% in the first quarter. Acadian Asset Management LLC now owns 1,107,469 shares of the company’s stock worth $8,009,000 after buying an additional 769,357 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. bought a new stake in shares of OraSure Technologies during the first quarter valued at approximately $127,000. TIAA CREF Investment Management LLC increased its stake in shares of OraSure Technologies by 3.2% in the first quarter. TIAA CREF Investment Management LLC now owns 586,982 shares of the company’s stock valued at $4,244,000 after buying an additional 18,442 shares during the period. Teachers Advisors Inc. increased its stake in shares of OraSure Technologies by 4.8% in the first quarter. Teachers Advisors Inc. now owns 1,360,199 shares of the company’s stock valued at $9,834,000 after buying an additional 62,173 shares during the period. Finally, Algert Global LLC bought a new stake in shares of OraSure Technologies during the first quarter valued at approximately $187,000. Institutional investors and hedge funds own 79.79% of the company’s stock.

OraSure Technologies Company Profile

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

5 Day Chart for NASDAQ:OSUR

Receive News & Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.